Amelioration of thyroid dysfunction by magnesium in experimental diabetes may also prevent diabetes-induced renal impairment

Abstract

Background Diabetes mellitus has been reported to cause thyroid dysfunction, which may also impair renal function. Magnesium has been reported to exert ameliorative effects in diabetes mellitus. This study investigated thyroid and renal functions in experimental type-2-diabetic Wistar rats. Methods Experimental type-2-diabetes was induced using short duration high-fat (30%) diet feeding followed by single-dose streptozotocin (35 mg/kg i.p.). Fifty rats were randomly divided into five equal groups consisting of control, diabetes untreated, diabetes treated with either magnesium (250 mg/kg) or metformin (250 mg/kg) and diabetes treated with both metformin and magnesium simultaneously. All treatments were carried out orally for 14days post-diabetes induction. Body weight and blood glucose was monitored using the tail tipping method before diabetes induction and thereafter on days 1,7,14 post-treatment respectively. Thereafter, blood samples were collected by cardiac puncture after light anesthesia into plain and EDTA sample bottles. Total protein, albumin, globulin (plasma) and insulin (serum) were assayed in all samples obtained. Thyroid stimulating hormone (TSH), triiodothyronine, thyroxine was also evaluated (n = 5/group) in serum while blood urea nitrogen (BUN), creatinine was assessed (n = 5/group) in plasma. Kidney homogenates were obtained per group and analyzed for renal superoxide dismutase (SOD), reduced glutathione (GSH) and lipid peroxidation (MDA). Kidney histology was also evaluated per group using both Haematoxylin and Eosin and periodic acid Schiff stains. Results Body weight, blood glucose, insulin, renal MDA was increased in diabetic untreated compared to other groups. Reductions (P < 0.05) in TSH, triiodothynine, Renal SOD and GSH levels where observed in diabetic untreated compared to other groups. Renal histology in diabetic untreated showed glomerula sclerosis, fused messengial cells and either collapsed tubular lumen or lumen with eosinophilic renal cast. These pathologies where partially reversed in the other experimental groups. Conclusion This study suggests that thyroid and renal impairment may be present in experimental type-2-diabetes. Treatment with oral magnesium may cause a partial restoration of thyroid function that may impede the development of renal dysfunction.

Cardioprotective role of metformin against sodium arsenite‐induced oxidative stress, inflammation, and apoptosis

“…A preclinical study of cardiac failure and myocardial infarction (MI) has demonstrated that metformin expands the resilience of the heart to ischemia–reperfusion damage and, after infarction, diminishes the advancement of heart failure . The UK Prospective Diabetes Study (UKPDS) showed that metformin beneficially affects diverse cardiovascular hazard factors . Metformin treatment resulted in a 30% lower risk of macrovascular diseases contrasted with the other treatment modalities in the UKPDS .…”

“…9,10 The UK Prospective Diabetes Study (UKPDS) showed that metformin beneficially affects diverse cardiovascular hazard factors. 11,12 Metformin treatment resulted in a 30% lower risk of macrovascular diseases contrasted with the other treatment modalities in the UKPDS. 13,14 For MI alone, the metformin group had a 42% lesser chance than the traditional treatment group.…”

Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers

“…AFE has a hypoglycemic effect in normal and diabetic mice [7]. Hyperglycemia usually accompanies the increased thyroid-stimulating hormone (TSH), triiodothyronine, and thyroxine levels [74]. AFE suppresses PD-L1 expression in the normal serum culture condition, which contains thyroid hormone and steroid hormones.…”

Morphological changes in the thyroid gland of rats after magnesium chloride ingestion

“…Доказана лечебно-терапевтическая роль магния при повреждении ЩЖ. Так, выявлено, что пероральное введение магния способно вызывать частичное восстановление функции ЩЖ у экспериментальных крыс с диабетом 2-го типа [20].…”